These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33354859)

  • 1. N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials.
    Nery FG; Li W; DelBello MP; Welge JA
    Bipolar Disord; 2021 Nov; 23(7):707-714. PubMed ID: 33354859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials.
    Kishi T; Miyake N; Okuya M; Sakuma K; Iwata N
    Psychopharmacology (Berl); 2020 Nov; 237(11):3481-3487. PubMed ID: 32767039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of N-acetylcysteine on bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
    Pittas S; Theodoridis X; Haidich AB; Bozikas PV; Papazisis G
    Psychopharmacology (Berl); 2021 Jul; 238(7):1729-1736. PubMed ID: 33641060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study.
    Ellegaard PK; Licht RW; Nielsen RE; Dean OM; Berk M; Poulsen HE; Mohebbi M; Nielsen CT
    J Affect Disord; 2019 Feb; 245():1043-1051. PubMed ID: 30699846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials.
    Zheng W; Zhang QE; Cai DB; Yang XH; Qiu Y; Ungvari GS; Ng CH; Berk M; Ning YP; Xiang YT
    Acta Psychiatr Scand; 2018 May; 137(5):391-400. PubMed ID: 29457216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo.
    Berk M; Turner A; Malhi GS; Ng CH; Cotton SM; Dodd S; Samuni Y; Tanious M; McAulay C; Dowling N; Sarris J; Owen L; Waterdrinker A; Smith D; Dean OM
    BMC Med; 2019 Jan; 17(1):18. PubMed ID: 30678686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Acetylcysteine Augmentation for Patients With Major Depressive Disorder and Bipolar Depression.
    Andrade C
    J Clin Psychiatry; 2021 Feb; 82(1):. PubMed ID: 33999540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.
    Berk M; Copolov DL; Dean O; Lu K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Bush AI
    Biol Psychiatry; 2008 Sep; 64(6):468-75. PubMed ID: 18534556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline serum amino acid levels predict treatment response to augmentation with N-acetylcysteine (NAC) in a bipolar disorder randomised trial.
    Bortolasci CC; Turner A; Mohebbi M; Liu ZS; Ashton M; Gray L; Marx W; Walker AJ; Kowalski GM; Jacka F; Berk M; Dean OM; Walder K
    J Psychiatr Res; 2021 Oct; 142():376-383. PubMed ID: 34438354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
    Goss AJ; Kaser M; Costafreda SG; Sahakian BJ; Fu CH
    J Clin Psychiatry; 2013 Nov; 74(11):1101-7. PubMed ID: 24330897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression.
    Bauer IE; Green C; Colpo GD; Teixeira AL; Selvaraj S; Durkin K; Zunta-Soares GB; Soares JC
    J Clin Psychiatry; 2018 Dec; 80(1):. PubMed ID: 30549489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
    Papakostas GI; Martinson MA; Fava M; Iovieno N
    J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis.
    Fernandes BS; Dean OM; Dodd S; Malhi GS; Berk M
    J Clin Psychiatry; 2016 Apr; 77(4):e457-66. PubMed ID: 27137430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylcysteine for major depressive episodes in bipolar disorder.
    Magalhães PV; Dean OM; Bush AI; Copolov DL; Malhi GS; Kohlmann K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Berk M
    Braz J Psychiatry; 2011 Dec; 33(4):374-8. PubMed ID: 22189927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.
    McGirr A; Vöhringer PA; Ghaemi SN; Lam RW; Yatham LN
    Lancet Psychiatry; 2016 Dec; 3(12):1138-1146. PubMed ID: 28100425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial.
    Berk M; Dean O; Cotton SM; Gama CS; Kapczinski F; Fernandes BS; Kohlmann K; Jeavons S; Hewitt K; Allwang C; Cobb H; Bush AI; Schapkaitz I; Dodd S; Malhi GS
    J Affect Disord; 2011 Dec; 135(1-3):389-94. PubMed ID: 21719110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials.
    Bartoli F; Cavaleri D; Bachi B; Moretti F; Riboldi I; Crocamo C; Carrà G
    J Psychiatr Res; 2021 Nov; 143():230-238. PubMed ID: 34509090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allopurinol augmentation in acute mania: A meta-analysis of placebo-controlled trials.
    Chen AT; Malmstrom T; Nasrallah HA
    J Affect Disord; 2018 Jan; 226():245-250. PubMed ID: 29017068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical Trials.
    Fornaro M; Stubbs B; De Berardis D; Perna G; Valchera A; Veronese N; Solmi M; Ganança L
    Int J Mol Sci; 2016 Feb; 17(2):241. PubMed ID: 26891297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.